Key result
Enalapril and losartan showed no significant difference in improving left ventricular ejection fraction after 6 months in patients with anterior-wall myocardial infarction.
Why the study?
Does enalapril or losartan improve left ventricular remodeling in Japanese patients after acute anterior-wall myocardial infarction?
RCT (n=100)
Single-blind
Randomly assigned
No
Does enalapril or losartan improve left ventricular remodeling in Japanese patients after acute anterior-wall myocardial infarction?
Enalapril and losartan demonstrated equivalent efficacy in suppressing left ventricular remodeling after acute anterior-wall myocardial infarction, with greater benefits observed in patients with poorer baseline LV function.
Answers are grounded in this paper and cite their sources.
Supports interchangeable use of either agent post-anterior MI; confirms ACEI-ARB equivalence for remodeling.
BACKGROUND: Angiotensin-converting enzyme inhibitors (ACE-I) and angiotensin II receptor blockers (ARB) have been shown to have a significant cardioprotective effect in high-risk patients after myocardial infarction (MI). However, there are few data on the effects of these drugs on left-ventricular (LV) remodeling after MI in Japanese patients. METHODS AND RESULTS: We randomly assigned 100 patients with anterior-wall MI who had received reperfusion therapy to treatment with either enalapril (n=50) or losartan (n=50), and calculated the LV ejection fraction (LVEF) and LV end-diastolic volume index (LVEDVI) in these patients at baseline and after 6 months of treatment. While a significant increase in the LVEF as compared with that at the baseline was observed in both groups, no significant difference was found in the rate of change of this parameter between the two groups. However, inverse correlations were observed between the baseline LVEF and LVEDVI and also the rates of change of the two parameters, suggesting that the greater the compromise of the LV function at baseline, the greater the preventive effect of both classes of drugs on LV remodeling. CONCLUSION: The results of this study suggest that neither enalapril nor losartan is superior to the other in terms of the effect on LV remodeling after MI in Japanese patients. In addition, the suppressive effect of both classes of drugs on LV remodeling was greater in patients with more extensive infarction and greater compromise of LV function at baseline.
No takes yet. Share an insight, caveat, or question.
Tani et al. (2009) conducted an RCT in Acute Myocardial Infarction (n=100). Enalapril vs. Losartan was evaluated on Percent change in left ventricular ejection fraction (LVEF) at 6 months (p=0.97). Enalapril and losartan showed no significant difference in improving left ventricular ejection fraction after 6 months in patients with anterior-wall myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: